Biogen Idec, Inc.
About
Biogen, listed here under its former name Biogen Idec, is a Cambridge biotechnology company that researches and sells medicines for serious and hard-to-treat diseases. The company is best known for its work in neurology, including treatments for multiple sclerosis and spinal muscular atrophy, and its pipeline also includes potential breakthrough therapies in immunology and rare diseases. It pursues first-in-class treatments using a range of scientific approaches.
The Biogen Idec name dates from the 2003 merger of Biogen and IDEC Pharmaceuticals; the company returned to the Biogen name in 2015. Founded in 1978, Biogen was among the first global biotechnology companies. Its website features patient stories and information about its pipeline, and the company describes its mission in terms of transforming rigorous science into first-in-class medicines that change patients’ lives.
What to Know
- Nobel laureates Walter Gilbert and Phillip Sharp were among the company’s founders.
- Biogen’s stated values are caring deeply, achieving excellence and changing lives.
- The company sells its medicines worldwide.
- It is a member of the Cambridge Chamber of Commerce.
Is this your business?
Claim it to add hours, photos, a description and a spotlight story.